Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Arch Phys Med Rehabil. 2013 Mar;94(3):575-8. doi: 10.1016/j.apmr.2012.08.214. Epub 2012 Sep 5.
To examine the association between Multiple Sclerosis Walking Scale-12 (MSWS-12) scores and spatiotemporal parameters of gait as indicators of gait quality among ambulatory persons with multiple sclerosis (MS).
Cross-sectional study.
University research laboratory.
Community-residing persons with MS (N=268).
Not applicable.
Main outcome measures included the MSWS-12 and spatial and temporal gait parameters (walking speed, cadence, step length, step time, base of support [ie, the distance between 1 footfall and the line of progression of the opposing foot], and percentage of gait cycle spent in double support). Secondary outcomes included the timed 25-foot walk (T25FW), 6-minute walk (6MW), and Patient-Determined Disease Steps scale.
MSWS-12 scores were significantly correlated with walking speed (r=-.59), cadence (r=-.50), step length (r=-.53), step time (r=.46), base of support (r=.29), and percentage of the gait cycle spent in double support (r=.54). MSWS-12 scores further were significantly correlated with T25FW (r=.57) and 6MW (r=-.75) scores.
Such findings suggest that the MSWS-12 captures aspects of walking quality, assessed as spatiotemporal parameters of gait, in addition to walking speed and endurance in persons with MS.
研究多发性硬化行走量表-12 (MSWS-12)评分与步态时空参数之间的关系,这些参数是衡量多发性硬化症患者步行质量的指标。
横断面研究。
大学研究实验室。
居住在社区的多发性硬化症患者(N=268)。
不适用。
主要观察指标包括 MSWS-12 和空间及时间步态参数(行走速度、步频、步长、步时、支撑基础[即一只脚的足印与对侧脚前进线之间的距离]和双支撑阶段占步态周期的百分比)。次要观察指标包括定时 25 英尺行走(T25FW)、6 分钟步行(6MW)和患者确定的疾病步骤量表。
MSWS-12 评分与行走速度(r=-.59)、步频(r=-.50)、步长(r=-.53)、步时(r=.46)、支撑基础(r=.29)和双支撑阶段占步态周期的百分比(r=.54)呈显著相关。MSWS-12 评分还与 T25FW(r=.57)和 6MW(r=-.75)评分显著相关。
这些发现表明,MSWS-12 除了测量多发性硬化症患者的行走速度和耐力外,还能捕捉到行走质量的方面,这些方面通过步态时空参数来评估。